- Home
- OCUP vs AIRT Comparison
OCUP vs AIRT Comparison
Compare OCUP & AIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCUP
- AIRT
- Stock Information
- Founded
- OCUP 2018
- AIRT 1980
- Country
- OCUP United States
- AIRT United States
- Employees
- OCUP N/A
- AIRT N/A
- Industry
- OCUP Biotechnology: Pharmaceutical Preparations
- AIRT Air Freight/Delivery Services
- Sector
- OCUP Health Care
- AIRT Consumer Discretionary
- Exchange
- OCUP Nasdaq
- AIRT Nasdaq
- Market Cap
- OCUP 53.1M
- AIRT 45.6M
- IPO Year
- OCUP N/A
- AIRT N/A
- Fundamental
- Price
- OCUP $1.32
- AIRT $18.48
- Analyst Decision
- OCUP Strong Buy
- AIRT
- Analyst Count
- OCUP 3
- AIRT 0
- Target Price
- OCUP $18.67
- AIRT N/A
- AVG Volume (30 Days)
- OCUP 85.2K
- AIRT 21.8K
- Earning Date
- OCUP 11-11-2024
- AIRT 11-11-2024
- Dividend Yield
- OCUP N/A
- AIRT N/A
- EPS Growth
- OCUP N/A
- AIRT N/A
- EPS
- OCUP N/A
- AIRT N/A
- Revenue
- OCUP $16,449,000.00
- AIRT $281,814,000.00
- Revenue This Year
- OCUP N/A
- AIRT N/A
- Revenue Next Year
- OCUP $258.69
- AIRT N/A
- P/E Ratio
- OCUP N/A
- AIRT N/A
- Revenue Growth
- OCUP N/A
- AIRT 5.20
- 52 Week Low
- OCUP $1.15
- AIRT $12.53
- 52 Week High
- OCUP $3.53
- AIRT $30.60
- Technical
- Relative Strength Index (RSI)
- OCUP 48.70
- AIRT 44.04
- Support Level
- OCUP $1.25
- AIRT $16.73
- Resistance Level
- OCUP $1.35
- AIRT $18.63
- Average True Range (ATR)
- OCUP 0.08
- AIRT 1.16
- MACD
- OCUP 0.01
- AIRT 0.08
- Stochastic Oscillator
- OCUP 29.17
- AIRT 45.29
About OCUP Ocuphire Pharma Inc.
Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.